Cover Image

Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and Carbapenem-Resistant <i>Escherichia coli</i>

The purpose was to explore the optimal dosage regimen of colistin using Monte Carlo simulations, for the treatment of carbapenem-resistant <i>Klebsiella pneumoniae</i> and carbapenem-resistant <i>Escherichia coli</i> based on PK/PD targets in critically ill patients. A total...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kamonchanok Jitaree (Author), Korbtham Sathirakul (Author), Jantana Houngsaitong (Author), Orarik Asuphon (Author), Weerayuth Saelim (Author), Visanu Thamlikitkul (Author), Preecha Montakantikul (Author)
Format:	Book
Published:	MDPI AG, 2019-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant <i>Acinetobacter baumannii</i> Using the Broth Microdilution Checkerboard and Time-Kill Methods
by: Vipavee Rodjun, et al.
Published: (2020)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022)

Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant <it>P. aeruginosa</it> in tertiary hospitals across Thailand
by: Khuntayaporn Piyatip, et al.
Published: (2012)

Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant <i>Klebsiella pneumoniae</i>
by: Tsung-Ying Yang, et al.
Published: (2021)

Molecular Characteristics and Quantitative Proteomic Analysis of <i>Klebsiella pneumoniae</i> Strains with Carbapenem and Colistin Resistance
by: Ling Hao, et al.
Published: (2022)

Colistin Dosing Regimens against <i>Pseudomonas aeruginosa</i> in Critically Ill Patients: An Application of Monte Carlo Simulation
by: Van Thi Khanh Nguyen, et al.
Published: (2021)

Correlation between Carbapenem Consumption and Carbapenems Susceptibility Profiles of <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i> in an Academic Medical Center in Thailand
by: Taniya Paiboonvong, et al.
Published: (2022)

Efficacy and Safety of Oral Neomycin for the Decolonization of Carbapenem-Resistant <i>Enterobacterales</i>: An Open-Label Randomized Controlled Trial
by: Lalita Tancharoen, et al.
Published: (2024)

Flow Cytometry as a Rapid and Valuable Method in Investigation of Colistin Resistance in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Isolates
by: Şafak Ceren Uçak, et al.
Published: (2024)

Optical DNA Mapping of Plasmids Reveals Clonal Spread of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in a Large Thai Hospital
by: Sriram KK, et al.
Published: (2021)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>
by: Paraskevi Mantzana, et al.
Published: (2023)

Prevalence of OXA-Type β-Lactamase Genes among Carbapenem-Resistant <em>Acinetobacter baumannii</em> Clinical Isolates in Thailand
by: Krit Thirapanmethee, et al.
Published: (2020)

Active Surveillance for Carbapenem-Resistant <i>Enterobacterales</i> (CRE) Colonization and Clinical Course of CRE Colonization among Hospitalized Patients at a University Hospital in Thailand
by: Walaiporn Wangchinda, et al.
Published: (2022)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021)

The Clash of the Titans: COVID-19, Carbapenem-Resistant <i>Enterobacterales,</i> and First <i>mcr-1</i>-Mediated Colistin Resistance in Humans in Romania
by: Ionela-Larisa Miftode, et al.
Published: (2023)

Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant <i>A.</i><i>baumannii</i> in Cancer Patient
by: Wasan Katip, et al.
Published: (2021)

Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Filomena Sannio, et al.
Published: (2022)

Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
by: Márió Gajdács
Published: (2020)

Effectiveness and Nephrotoxicity of Loading Dose Colistin-Meropenem versus Loading Dose Colistin-Imipenem in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
by: Wasan Katip, et al.
Published: (2022)

Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in COVID-19 Era-Challenges and Solutions
by: Jozef Ficik, et al.
Published: (2023)

Disinfection Strategies for Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in a Healthcare Facility
by: Lijia Ni, et al.
Published: (2022)

Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021)

Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients
by: Wasan Katip, et al.
Published: (2021)

Emergence of <i>bla</i><sub>NDM-5</sub> and <i>bla</i><sub>OXA-232</sub> Positive Colistin- and Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in a Bulgarian Hospital
by: Rumyana Markovska, et al.
Published: (2024)

Present and Future of Carbapenem-resistant <i>Enterobacteriaceae</i> (CRE) Infections
by: Beatriz Suay-García, et al.
Published: (2019)

The Characterisation of Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> in a Teaching Hospital in Malaysia
by: Min Yi Lau, et al.
Published: (2024)

Genetic Characterization of Carbapenem-Resistant <i>Klebsiella</i> spp. from Municipal and Slaughterhouse Wastewater
by: Mykhailo Savin, et al.
Published: (2022)

Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii-calcoaceticus Complex</i>
by: Rebeca Carvalho Lacerda Garcia, et al.
Published: (2023)

A Retrospective Whole-Genome Sequencing Analysis of Carbapenem and Colistin-Resistant <i>Klebsiella pneumoniae</i> Nosocomial Strains Isolated during an MDR Surveillance Program
by: Bernardina Gentile, et al.
Published: (2020)

Heterogeneity of colistin resistance mechanism in clonal populations of carbapenem-resistant Klebsiella pneumoniae in Vietnam
by: Bui Tien Sy, et al.
Published: (2024)

Surveillance and Genomic Analysis of Third-Generation Cephalosporin-Resistant and Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Complex in Germany
by: Kyriaki Xanthopoulou, et al.
Published: (2022)

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023)

First Case of Bacteraemia Due to Carbapenem-Resistant <i>Bacteroides faecis</i>
by: Charlotte Kaeuffer, et al.
Published: (2021)

Early Years of Carbapenem-Resistant <i>Enterobacterales</i> Epidemic in Abu Dhabi
by: Tibor Pál, et al.
Published: (2022)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2020)

Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Clinical Strains: A Challenge for Tertiary Care Hospitals
by: Aamir Jamal Gondal, et al.
Published: (2024)

Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing <i>Enterobacterales</i> and Differentiation of Carbapenem-Resistant <i>Enterobacterales</i>
by: Kentarou Takei, et al.
Published: (2023)

ANTIBIOTIC COMBINATIONS WITH COLISTIN AGAINST CARBAPENEM-RESISTANT Klebsiella pneumoniae - in vitro ASSESSMENT
by: Yuliya Marteva-Proevska, et al.
Published: (2018)

Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant <i>Escherichia coli</i>
by: Hye-Rim Kim, et al.
Published: (2021)